/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR
DISSEMINATION IN THE UNITED
STATES/
CALGARY, AB, Sept. 30, 2021 /CNW/ - Comprehensive
Healthcare Systems Inc. (formerly, Greenstone Capital Corp.) (TSXV:
CHS) (the "Company" or the "Resulting Issuer") is
pleased to announce the closing of its previously announced
qualifying transaction (the "Qualifying Transaction")
resulting in the reverse takeover of the Company by Comprehensive
Healthcare Systems Inc. ("CHS"), a private company
incorporated under the laws of Delaware.
The parties to the Qualifying Transaction will make their final
submission to the TSX Venture Exchange (the "Exchange") in
connection with the Exchange's issuance of its listing
bulletin.
It is anticipated that the Resulting Issuer Shares will commence
trading on the Exchange under the ticker symbol "CHS" on or about
October 8, 2021.
The Transaction
Effective September 29, 2021, as a
condition to the completion of the Qualifying Transaction,
Greenstone changed its name to "Comprehensive Healthcare Systems
Inc." and consolidated its share capital (the
"Consolidation") on the basis of 3.5322575 (old) common
shares for 1 (new) common share. Immediately following the
Consolidation, Greenstone Capital Corp. had an aggregate of
2,066,667 common shares outstanding. In addition, on September 29, 2021, CHS completed a stock split
of one pre-split common share of CHS for 2,178.2738 post-split
common shares of CHS.
Pursuant to the terms of the Qualifying Transaction,
CHS completed a statutory triangular merger (the
"Merger") under the General Corporation Law
(Delaware) with Greenstone Capital
USA Inc. and all of the issued and
outstanding securities of CHS were exchanged for securities (the
"Securities Exchange") of the Resulting Issuer on a
one-to-one basis, pursuant to the terms and conditions of a second
amended and restated merger agreement dated September 27, 2021 (the "Merger
Agreement"), a copy of which is available under the Company's
profile on SEDAR at www.sedar.com.
Further to Greenstone Capital Corp.'s news release dated
May 10, 2021, concurrent with the
completion of the Qualifying Transaction, CHS raised aggregate
gross proceeds in the amount of approximately $4,489,627.05 through the issuance of an
aggregate of 9,976,949 subscription receipts of CHS
("Subscription Receipts"). Concurrent with the closing of
the Qualifying Transaction, the Subscription Receipts were
converted into 9,976,949 common shares of Resulting Issuer Shares
("Resulting Issuer Shares") and approximately 4,988,467
common share purchase warrants of the Resulting Issuer pursuant to
the terms of a subscription receipt agreement between the Company,
Richardson Wealth Limited, and TSX Trust Company Canada dated
April 8, 2021 (the "SR
Agreement"). In addition, the escrowed proceeds were also
released in accordance with the provisions of the SR Agreement.
Following the completion of the Securities Exchange and the
conversion of the Subscription Receipts, the Resulting Issuer will
have approximately 68,303,955 Resulting Issuer Shares outstanding
comprised of the following:
- 41,333,333 Resulting Issuer Shares issued to existing holders
of common and preferred shares of CHS;
- 14,060,939 Resulting Issuer Shares issued upon the conversion
of the convertible debentures of CHS;
- 9,976,949 Resulting Issuer Shares issued to holders of the
Subscription Receipts;
- 2,066,667 Resulting Issuer Shares currently held by the former
shareholders of Greenstone Capital Corp.; and
- 866,067 Resulting Issuer Shares issued to certain finders in
connection with the completion of the Qualifying Transaction.
Further details regarding the Qualifying Transaction can be
found in the filing statement of the Resulting Issuer dated
September 28, 2021 (the "Filing
Statement"), a copy of which is available under the Company's
profile on SEDAR at www.sedar.com.
Escrowed Shares
On completion of the Qualifying Transaction, certain Principals
(as defined policies of the Exchange) of the Resulting Issuer
holding an aggregate of 33,196,406 Resulting Issuer Shares are
subject to escrow in accordance with Policy 5.4 – Escrow, Vendor
Consideration and Resale Restrictions of the Exchange
("Policy 5.4"), to be released in accordance with the
following schedule:
Release
Dates
|
Percentage of
Total Escrowed Securities to be Released
|
Total Number of
Escrowed Securities to be Released
|
Date of Final Exchange
Bulletin
|
5%
|
1,659,820
|
6 months from Final
Exchange Bulletin
|
5%
|
1,659,820
|
12 months from Final
Exchange Bulletin
|
10%
|
3,319,640
|
18 months from Final
Exchange Bulletin
|
10%
|
3,319,640
|
24 months from Final
Exchange Bulletin
|
15%
|
4,979,460
|
30 months from Final
Exchange Bulletin
|
15%
|
4,979,460
|
36 months from Final
Exchange Bulletin
|
40%
|
13,278,566
|
TOTAL
|
100%
|
33,196,406
|
In addition, certain former shareholders of the Company entered
into a CPC Escrow Agreement (the "CPC Escrow Agreement")
with the Exchange and TSX Trust Company, as escrow agent, in
respect of 641,231 Resulting Issuer Shares. Under the terms of the
CPC Escrow Agreement, 25% of the escrowed shares will be released
at the time of the Final Exchange Bulletin, with an additional 25%
released on each 6 month anniversary thereafter. TSX Trust Company
acts as escrow agent in respect of the CPC Escrow Agreement.
In addition, on completion of the Qualifying Transaction,
certain former shareholders of CHS holding an aggregate of
8,105,801 Resulting Issuer Shares are subject to seed share resale
restrictions ("SSRR") pursuant to section 10 of Policy 5.4
and have entered into Value Security Escrow Agreement (as such term
is defined under the policies of the Exchange) with TSX Trust
Company.
On completion of the Qualifying Transaction, certain former
shareholders of CHS holding an aggregate of 30,968,136 Resulting
Issuer Shares are subject to a contractual lock up period of one
year from the date of completion of the Qualifying Transaction.
Where securities held by shareholders subject to the contractual
lock up period are also subject to escrow in accordance with
Exchange policies and applicable securities laws, the more
restrictive escrow/lock-up regime shall govern.
Board of Directors and Executive Management
Following the completion of the Qualifying Transaction, the
following individuals comprise the directors and officers of the
Company:
· Dr.
Hassan Mohaideen
|
-
|
Chief Executive
Officer, Chairman, Director
|
·
Alex McAulay
|
-
|
Chief Financial
Officer
|
·
Mariam Cather
|
-
|
Chief Strategy
Officer, Corporate Secretary, Director
|
·
Amit Dutta
|
-
|
Director
|
·
Vikas Ranjan
|
-
|
Director
|
· Dr.
Fiona Gupta
|
-
|
Director
|
· Mo
Fazil
|
-
|
Director
|
Auditors
Concurrent with the closing of the Qualifying Transaction, Dale
Matheson Carr-Hilton LaBonte LLP, has been appointed auditors of
the Company.
Additional Information for Shareholders
The Company's transfer agent, TSX Trust Company, will be mailing
Direct Registration System statements to all former securityholders
of CHS (other than for those that are required to be in
certificated form) setting out each holder's shareholdings. The
CUSIP number for Resulting Issuer Shares is 204663108.
Former holders of pre-Consolidation common shares of Greenstone
will be receiving by mail, from TSX Trust Company, a letter of
transmittal with instructions on how to remit their former common
shares of Greenstone Capital Corp. for Resulting Issuer Shares.
For further information, please refer to the Filing Statement
posted to the Company's issuer profile on SEDAR at www.sedar.com,
as well as the press releases dated December
9, 2020, February 24, 2021,
and May 10, 2021.
About Comprehensive Healthcare Systems Inc.
Comprehensive Healthcare Systems Inc. is a corporation
incorporated under the laws of the state of Delaware. The Company is a vertically
integrated software as a services (SaaS) company focused on
digitizing healthcare with Telehealth and Healthcare Benefits
Administration solutions, providing reliable and high-volume
transaction capable systems. The Company's state of the art NPS
Novus Healthcare Welfare and Benefits Administration (HWBA) SaaS
platform is used by clients for all aspects of healthcare benefit
administration (including insurance companies, hospitals, doctors
and labor unions, through various corporation in which the majority
shareholder has controlling ownership), providing healthcare
administrative software, licensing and maintenance services.
Disclaimer
Investors are cautioned that, except as disclosed in the
Filing Statement prepared in connection with the Qualifying
Transaction, any information released or received with respect to
the Qualifying Transaction may not be accurate or complete and
should not be relied upon. Trading in the securities of the Company
should be considered highly speculative.
The TSXV has in no way passed upon the merits of the
Qualifying Transaction and has neither approved nor disapproved the
contents of this news release.
Neither the Exchange nor its Regulation Service Provider
(as defined policies of the Exchange) accepts responsibility for
the adequacy or accuracy of this press release.
This news release shall not constitute an offer to sell or
the solicitation of an offer to buy any securities in any
jurisdiction. Any securities referred to herein have not been, nor
will they be, registered under the United States Securities Act of
1933, as amended, and may not be offered or sold in the United States or to a U.S. Person absent
registration or an applicable exemption from the registration
requirements of the United States Securities Act of 1933, as
amended, and applicable state securities laws.
Forward-Looking Statements
This press release may contain certain forward-looking
information and statements ("forward-looking information") within
the meaning of applicable Canadian securities legislation, that are
not based on historical fact, including without limitation
statements containing the words "believes", "anticipates", "plans",
"intends", "will", "should", "expects", "continue", "estimate",
"forecasts" and other similar expressions. Readers are
cautioned to not place undue reliance on forward-looking
information. Actual results and developments may differ materially
from those contemplated by these statements. The Company undertakes
no obligation to comment analyses, expectations or statements made
by third-parties in respect of the Company, its securities, or
financial or operating results (as applicable). Although the
Company believes that the expectations reflected in forward-looking
information in this press release are reasonable, such
forward-looking information has been based on expectations, factors
and assumptions concerning future events which may prove to be
inaccurate and are subject to numerous risks and uncertainties,
certain of which are beyond the Company's control, including the
risk factors discussed in the Filing Statement which are
incorporated herein by reference and are available through SEDAR at
www.sedar.com. The forward-looking information contained in this
press release are expressly qualified by this cautionary statement
and are made as of the date hereof. The Company disclaims any
intention and has no obligation or responsibility, except as
required by law, to update or revise any forward-looking
information, whether as a result of new information, future events
or otherwise.
Share numbers noted in this press release may not match the
numbers disclosed in the Filing Statement due to rounding pursuant
to the process of completing the Consolidation and the exchange of
CHS securities for post-Consolidation common shares.
SOURCE Comprehensive Healthcare Systems Inc.